Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Rev. bras. hipertens ; 22(4): 112-118, out.-dez.2015.
Article in Portuguese | LILACS | ID: biblio-881219

ABSTRACT

O texto discute a importância de se avaliar a hemodinâmica central no tratamento da hipertensão arterial sistêmica. Parâmetros de avaliação da pressão central, tais como pressão sistólica central, augmentation index e velocidade de onda de pulso representam melhores marcadores de desfechos cardiovasculares do que a medida periférica da pressão arterial. Nessa revisão também são mostrados os efeitos comparativos de diferentes classes de anti-hipertensivos e outros fármacos sobre a hemodinâmica central, incluindo diuréticos, betabloqueadores, antagonistas dos canais de cálcio, inibidores da enzima conversora da angiotensina, bloqueadores dos receptores AT1 da angiotensina II, nitratos, antagonistas da aldosterona e inibidor direto da renina, além de estatinas, antidiabéticos orais e anti-inflamatórios


The paper discusses the importance of evaluating the central hemodynamic in the treatment of hypertension. Evaluation parameters of the central pressure such as the central systolic blood pressure, augmentation index and pulse wave velocity represent better markers of cardiovascular outcomes than the peripheral measurement of blood pressure. Finally, the comparative effects of various antihypertensive classes and other drugs on central haemodynamic are shown, including diuretics, beta-blockers, calcium channels antagonists, angiotensin converting enzyme inhibitors, angiotensin II AT1 receptor blockers, nitrates, antagonists aldosterone, renin inhibitor, as well as statins, oral antidiabetic and anti-inflammatory drugs


Subject(s)
Antihypertensive Agents , Hemodynamics , Hypertension , Pulse Wave Analysis , Vascular Stiffness
2.
Rev. bras. hipertens ; 20(3): 122-127, jul.-set.2013.
Article in Portuguese | LILACS | ID: biblio-881636

ABSTRACT

A insuficiência cardíaca (IC) constitui-se numa das principais complicações da hipertensão arterial (HA). A coexistência das duas situações (HA e IC) demanda algumas particularidades na condução do tratamento. O tratamento não farmacológico envolve mudanças no estilo de vida e cautela na ingestão de sal. A literatura tem mostrado que algumas classes de fármacos são mais benéficas que outras, pois são capazes de aumentar a sobrevida de pacientes com IC. Destacam-se os Inibidores da Enzima Conversora da Angiotensina (IECA), os Betabloqueadores (BB) e os Antagonistas da Aldosterona. Os Bloqueadores dos Receptores de Angiotensina (BRA) no tratamento da IC parecem ser tão efetivos quanto, ou, possivelmente, levemente menos efetivos do que os IECA quando comparados diretamente.


Heart failure (HF) is one of the main complications of hypertension. The coexistence of both conditions requires special concerns on treatment management. Non pharmacological treatment involves life style changes and care in salt intake. Literature has showed that many classes of drugs are proven to be more effective, because they can enhance HF patients' survival. Between then, Angiotensin-Converting Enzyme Inhibitors (ACEI), Beta-blockers (BB), and the Aldosterone Antagonists (AA) are proven to be the more efficient drugs. The Angiotensin Receptor Blockers (ARB) are as effective as, or possibly mild less effective than ACEI when they were directly compared.


Subject(s)
Antihypertensive Agents , Heart Failure , Hypertension/therapy
3.
Journal of Vietnamese Medicine ; : 17-21, 2005.
Article in Vietnamese | WPRIM | ID: wpr-4401

ABSTRACT

This research was carried out on 39 patients between 40 and 70 of ages, who had hypertension of degree I, II, with hyperlipaemia but without complications. Total cholesterol, serum triglyceride were quantified according to enzyme method on automatic biochemical analysis machine. The results showed that: concentration of total cholesterol in these 39 patients who treated with antihypertensive herbal remedy Nguu tat, Hoe hoa, Linh chi 3g/day during 30 days decreased clearly (8.6%), serum triglyceride concentration reduced 0.32mmpl/l (~9.94%)


Subject(s)
Hypertension , Cholesterol , Triglycerides , Plasma
SELECTION OF CITATIONS
SEARCH DETAIL